Microbot Medical Statistics
Share Statistics
Microbot Medical has 36.38M
shares outstanding. The number of shares has increased by 117.62%
in one year.
| Shares Outstanding | 36.38M |
| Shares Change (YoY) | 117.62% |
| Shares Change (QoQ) | 105.2% |
| Owned by Institutions (%) | 6.7% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 93,106 |
| FTD / Avg. Volume | 3.93% |
Short Selling Information
The latest short interest is 6.41M, so 17.66% of the outstanding
shares have been sold short.
| Short Interest | 6.41M |
| Short % of Shares Out | 17.66% |
| Short % of Float | 17.73% |
| Short Ratio (days to cover) | 2.35 |
Valuation Ratios
The PE ratio is 96.27 and the forward
PE ratio is null.
Microbot Medical's PEG ratio is
-0.95.
| PE Ratio | 96.27 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | 16.1 |
| PB Ratio | 4.96 |
| P/FCF Ratio | -1.98 |
| PEG Ratio | -0.95 |
Financial Ratio HistoryEnterprise Valuation
Microbot Medical has an Enterprise Value (EV) of 14.52M.
| EV / Sales | 0 |
| EV / EBITDA | -1.28 |
| EV / EBIT | -1.64 |
| EV / FCF | -1.64 |
Financial Position
The company has a current ratio of 2.37,
with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.37 |
| Quick Ratio | 2.37 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 5.16% and Return on Invested Capital is -319.28%.
| Return on Equity | 5.16% |
| Return on Assets | 3.02% |
| Return on Invested Capital | -319.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | $9,100 |
| Employee Count | 20 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 159.8% in the
last 52 weeks. The beta is 1.15, so Microbot Medical's
price volatility has been higher than the market average.
| Beta | 1.15 |
| 52-Week Price Change | 159.8% |
| 50-Day Moving Average | 2.12 |
| 200-Day Moving Average | 1.46 |
| Relative Strength Index (RSI) | 59.24 |
| Average Volume (20 Days) | 2,367,533 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.63M |
| Net Income | 182K |
| EBITDA | -11.35M |
| EBIT | -11.44M |
| Earnings Per Share (EPS) | 0.01 |
Full Income StatementBalance Sheet
The company has 3.11M in cash and 111K in
debt, giving a net cash position of 3M.
| Cash & Cash Equivalents | 3.11M |
| Total Debt | 111K |
| Net Cash | 3M |
| Retained Earnings | -90.94M |
| Total Assets | 30.89M |
| Working Capital | 28.76M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -8.83M
and capital expenditures -25K, giving a free cash flow of -8.85M.
| Operating Cash Flow | -8.83M |
| Capital Expenditures | -25K |
| Free Cash Flow | -8.85M |
| FCF Per Share | -0.57 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
